Description

Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared to patients not using digoxin. Results of the studies suggested that digoxin use may be linked with a higher risk of death when compared to patients not using digoxin, especially among patients diagnosed with an irregular heart rhythm.

Resources

Name	Format	Description	Link
Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-lanoxin-toloxin-digoxin-digoxin-digoxin-assessing-potential-higher-risk-death-compared-patients-using-digoxin.html
Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-lanoxin-toloxin-digoxin-digoxin-digoxine-evaluation-potentiel-risque-deces-accru-chez-patients-traites-digoxine.html

Tags

Topics

Categories